Optimal timing for initiation of highly active antiretroviral therapy in treatment-naïve human immunodeficiency virus-1-infected individuals presenting with AIDS-defining diseases: The experience of the PISCIS Cohort

  1. Manzardo, C.
  2. Esteve, A.
  3. Ortega, N.
  4. Podzamczer, D.
  5. Murillas, J.
  6. Segura, F.
  7. Force, L.
  8. Tural, C.
  9. Vilaró, J.
  10. Masabeu, A.
  11. Garcia, I.
  12. Guadarrama, M.
  13. Ferrer, E.
  14. Riera, M.
  15. Navarro, G.
  16. Clotet, B.
  17. Gatell, J.M.
  18. Casabona, J.
  19. Miró, J.M.
Journal:
Clinical Microbiology and Infection

ISSN: 1469-0691 1198-743X

Year of publication: 2013

Volume: 19

Issue: 7

Pages: 646-653

Type: Article

DOI: 10.1111/J.1469-0691.2012.03991.X GOOGLE SCHOLAR lock_openOpen access editor